Evidence map›Paper›PMID 41341908›Full record

ArticleIntractable & rare diseases research2025

Characteristics of rare diseases cases: A summary analysis of hospitalized patients at a hospital in Western China from 2015 to 2023.

Qi Wang, Liang Guo, Yan Yang, Jin He

Abstract read
In one paragraph

Article in Intractable & rare diseases research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qi WangMedical Affairs Department, Gansu Provincial Hospital, Lanzhou, Gansu, China.
Liang GuoDepartment of General Surgery, Ward 6, The Second Hospital of Lanzhou University, Lanzhou, Gansu, China.
Yan YangQuality Control Department, Gansu Provincial Hospital, Lanzhou, Gansu, China.
Jin HeMedical Affairs Department, Gansu Provincial Hospital, Lanzhou, Gansu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rare diseases, characterized by low prevalence and high heterogeneity, impose a significant burden on patients and healthcare systems globally. Utilizing clinical data from the Hospital Information System's Patient Discharge Summaries (2015-2023), we analyzed all rare disease inpatient admissions at a major tertiary hospital in Western China. We examined demographic characteristics, classification of disease systems, medical costs, and readmission rate. Among 1086 inpatient admissions identified with rare diseases (mean age: 46.89 ±18.99 years), diseases of the nervous system (39.69%), the blood and blood-forming organs and certain disorders involving the immune mechanism (18.32%), the musculoskeletal system and connective tissue (10.50%) constituted the top three disease system categories. The number of the top15 diseases accounted for 73.66% of the total number of patients. The top 3 diseases were POEMS syndrome (11.23%), optical neuromyelitis (10.22%), and Castleman disease (7.46%). Hospitalization costs were predominantly composed of diagnostic (ranged from 6.41% to 49.75%) and medication costs (ranged from 12.97% to 46.22%). The 10 highest readmission rates ranged from 42.86% to 95.90%. The rare diseases in this hospital had a large age span, diverse disease types, high hospitalization costs and large individual differences, which was representative to a certain extent, and can provide scientific basis for the diagnosis, treatment, and prevention of rare diseases in Gansu Province and even the northwest region of China.

Indexed as

epidemiologyin-hospital analysisrare diseasesWestern China

Identifiers

PMID41341908
PMCPMC12672152

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.